文献
J-GLOBAL ID:201802232914254951
整理番号:18A0396832
米国における痛風の初期尿酸低下療法を導くためのHLA5801スクリーニングの費用対効果【Powered by NICT】
The cost-effectiveness of HLA-B*5801 screening to guide initial urate-lowering therapy for gout in the United States
著者 (6件):
Jutkowitz Eric
(Division of Health Policy and Management, School of Public Health, University of Minnesota, MMC 729, 420 Delaware St SE, Minneapolis, MN 55455)
,
Dubreuil Maureen
(Section of Clinical Epidemiology, Boston University School of Medicine, Boston, MA)
,
Dubreuil Maureen
(Section of Rheumatology, VA Boston Healthcare System, Boston, MA)
,
Lu Na
(Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA)
,
Kuntz Karen M.
(Division of Health Policy and Management, School of Public Health, University of Minnesota, MMC 729, 420 Delaware St SE, Minneapolis, MN 55455)
,
Choi Hyon K.
(Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA)
資料名:
Seminars in Arthritis and Rheumatism
(Seminars in Arthritis and Rheumatism)
巻:
46
号:
5
ページ:
594-600
発行年:
2017年
JST資料番号:
A1187A
ISSN:
0049-0172
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)